These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29673458)
1. [Elevated expression of CLOCK is associated with poor prognosis in hepatocellular carcinoma]. Li B; Yang X; Li J; Yang Y; Yan Z; Zhang H; Mu J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):163-168. PubMed ID: 29673458 [TBL] [Abstract][Full Text] [Related]
2. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. Chen Y; Yang S; Hu J; Yu C; He M; Cai Z PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310 [TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma. Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205 [TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
9. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
11. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Zhang D; Ma X; Sun W; Cui P; Lu Z Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876 [TBL] [Abstract][Full Text] [Related]
12. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma. Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma. Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759 [TBL] [Abstract][Full Text] [Related]
16. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma. Hu X; He B; Zhou L; Xie H; Zheng S Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933 [TBL] [Abstract][Full Text] [Related]
17. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Zhou Y; Zhou N; Fang W; Huo J Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
19. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma. Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838 [TBL] [Abstract][Full Text] [Related]
20. Dysregulation of metallothionein and circadian genes in human hepatocellular carcinoma. Li H; Lu YF; Chen H; Liu J Chronobiol Int; 2017; 34(2):192-202. PubMed ID: 27997226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]